mos Health (US:COSM) Globenewswire·2025-12-02 17:15Core Insights - Cosmos Health Inc. has seen significant share acquisitions by CEO Greg Siokas, who purchased 301,101 shares between November 19 and November 28, 2025, increasing his total ownership to 6,459,985 shares [1][2][3] - The company reported record-breaking Q3 2025 results, with strong growth across all core business segments, yet its valuation remains under pressure despite these achievements [2][3] Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada, owning a portfolio of proprietary pharmaceutical and nutraceutical brands [4] - The company manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices under European Good Manufacturing Practices (GMP) and is certified by the European Medicines Agency (EMA) [4] - Cosmos Health distributes a wide range of pharmaceuticals and parapharmaceuticals through subsidiaries in Greece and the UK, and has established R&D partnerships targeting major health disorders enhanced by artificial intelligence technologies [4] Recent Developments - CEO Greg Siokas has expressed strong confidence in the company's future, stating that he has increased his ownership by over 3 million shares since the beginning of 2025, indicating a commitment to support the company's objectives [2][3] - The company is expanding its global distribution platform throughout Europe, Asia, and North America, with offices and distribution centers in Greece and the UK [4]